CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The GET-IN project focuses on advancing gene therapy by addressing manufacturing challenges and improving delivery methods. It aims to develop scalable bioprocessing technologies and humanized models to enhance the efficacy and safety of gene therapies for larger patient populations.
Gene therapy has transitioned from a distant hope to reality.
To date 3 rAAV gene therapies are approved in the EU, >30 phase III clinical trials ongoing, and exciting developments in therapeutic gene editing in the pipeline.
However, fundamental limitations in the bioprocessing of gene therapy vectors limit broader application.
Manufacturing is not automated, with an open process environment, limited scalability and robustness, and inefficient downstream processing, resulting in huge footprint…
KATHOLIEKE UNIVERSITEIT LEUVEN
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Germany, Tuebingen
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Italy, Trento
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
ARISTOTLE UNIVERSITY OF THESSALONIKI
Greece, THESSALONIKI
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
